VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Revenue

VYNE Therapeutics had revenue of $169.00K in the quarter ending September 30, 2025, with 39.67% growth. This brings the company's revenue in the last twelve months to $524.00K, up 6.29% year-over-year. In the year 2024, VYNE Therapeutics had annual revenue of $501.00K with 18.16% growth.

• Revenue (ttm): $524.00K
• Revenue Growth: +6.29%
• P/S Ratio: 45.61
• Revenue / Employee: $40,308
• Employees: 13
• Market Cap: 18.53M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	501.00K	77.00K	18.16%
Dec 31, 2023	424.00K	-53.00K	-11.11%
Dec 31, 2022	477.00K	-454.00K	-48.76%
Dec 31, 2021	931.00K	-20.06M	-95.57%
Dec 31, 2020	20.99M	20.55M	4,638.83%
Dec 31, 2019	443.00K	-3.15M	-87.68%
Dec 31, 2018	3.60M	-987.00K	-21.54%
Dec 31, 2017	4.58M	3.91M	579.82%
Dec 31, 2016	674.00K	-	-
Dec 31, 2015	-	-	-